Stockscreener 앱 받기
0.722
1.77%
-0.013
시간 외 거래:
.72
-0.002
-0.28%
전일 마감가:
$0.735
열려 있는:
$0.72
하루 거래량:
52,192
Relative Volume:
0.29
시가총액:
$23.05M
수익:
$7.11M
순이익/손실:
$-41.28M
주가수익비율:
-0.5232
EPS:
-1.38
순현금흐름:
$-26.84M
1주 성능:
-7.79%
1개월 성능:
-7.44%
6개월 성능:
-33.76%
1년 성능:
-38.29%
1일 변동 폭
$0.72
$0.7459
1주일 범위
$0.72
$0.8399
52주 변동 폭
$0.67
$2.2299
Co Diagnostics Inc Stock (CODX) Company Profile
명칭
Co Diagnostics Inc
전화
(801) 278-9769
주소
4049 SOUTH HIGHLAND DRIVE, SALT LAKE CITY
CODX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CODX
Co Diagnostics Inc
|
0.722 | 23.05M | 7.11M | -41.28M | -26.84M | -1.38 |
|
ABT
Abbott Laboratories
|
129.10 | 223.92B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
103.54 | 152.60B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
392.39 | 149.59B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.97 | 116.65B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
71.33 | 42.07B | 6.60B | 4.16B | 490.10M | 6.93 |
Co Diagnostics Inc Stock (CODX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-12 | 다운그레이드 | Sidoti | Buy → Neutral |
| 2021-12-29 | 개시 | Sidoti | Buy |
| 2021-03-29 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-05-20 | 업그레이드 | Maxim Group | Hold → Buy |
| 2020-05-18 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-09 | 재확인 | H.C. Wainwright | Buy |
| 2020-03-03 | 다운그레이드 | Maxim Group | Buy → Hold |
모두보기
Co Diagnostics Inc 주식(CODX)의 최신 뉴스
Co-Diagnostics, Inc. Reports Second Quarter 2024 Financial Resul - GuruFocus.com
Co-Diagnostics, Inc. to Exhibit at BioUtah's 2025 Life Sciences Day on the Hill - WV News
Co-Diagnostics, Inc.: Live from Silicon Slopes - Nasdaq
CODX FINAL DEADLINE: ROSEN, A LEADING FIRM, Encourages Co-Diagnostics, Inc. Investors to Contact Firm Before Important August 17 Deadline in Securities Class Action Seeking Recovery of Investor LossesCODX - AccessWire
Quest Diagnostics (DGX) Stock Price, News & Analysis - MarketBeat
Jane Street Group LLC Makes New $55,000 Investment in Co-Diagnostics, Inc. (NASDAQ:CODX) - Defense World
CODX (Co-Diagnostics) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics faces potential Nasdaq delisting over share price - Investing.com
Co-Diagnostics faces potential Nasdaq delisting over share price By Investing.com - Investing.com Nigeria
Co-Diagnostics, Inc. to Participate at the Nasdaq Live from MarketSite Broadcast at Silicon Slopes 2025 - PR Newswire
Head to Head Contrast: Co-Diagnostics (NASDAQ:CODX) vs. Vasamed (OTCMKTS:VSMD) - Defense World
Co-Diagnostics (NASDAQ:CODX) and Aethlon Medical (NASDAQ:AEMD) Critical Review - Defense World
Co-Diagnostics, Inc. Announces Second Quarter 2024 Earnings Rele - GuruFocus.com
Financial Review: Co-Diagnostics (NASDAQ:CODX) & Endologix (OTCMKTS:ELGXQ) - Defense World
Co-Diagnostics stock hits 52-week low at $0.79 amid market challenges - Investing.com
CoSara Diagnostics inaugurates new oligo facility in Ranoli, Gujarat - BSI bureau
Co-Diagnostics, Inc. and CoSara Diagnostics to Inaugurate New Oligo Facility - Marketscreener.com
Co-Diagnostics, Inc. Announces Third Quarter 2024 Earnings Release Date and Webcast - The Eastern Progress Online
Make in India: CoSara Diagnostics to open oligo facility in Ranoli - Medical Buyer
Co-Diagnostics, Inc. to Accompany Utah Governor and WTC Utah on Trade Mission to South Korea and Japan - The Eastern Progress Online
Co-Diagnostics stock hits 52-week low at $0.85 amid market challenges - Investing.com Canada
Co-Diagnostics (FRA:C97) Earnings Yield % : N/A% (As of Dec. 05, 2024) - GuruFocus.com
Co-Diagnostics (FRA:C97) Enterprise Value : €-6.97 Mil (As of Dec. 05, 2024) - GuruFocus.com
Co-Diagnostics (STU:C97) Momentum Rank : 7 (As of Dec. 05, 2024) - GuruFocus.com
Co-Diagnostics (FRA:C97) EBITDA per Share : €-1.18 (TTM As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (FRA:C97) 3-Year FCF Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Price-to-Operating-Cash-Flow : (As of Dec. 01, 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) 50-Day SMA : €1.07 (As of Nov. 30, 2024) - GuruFocus.com
Rabies Diagnostics Market Report Details Trends and Growth Analysis Report 2024 - WhaTech
Co-Diagnostics (HAM:C97) Cash Flow from Operations : €-23.54 Mil (TTM As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Forward Rate of Return (Yacktman) % : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Change In Inventory : €0.32 Mil (TTM As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Forward Dividend Yield % : 0.00% (As of Nov. 26, 2024) - GuruFocus.com
CODX (Co-Diagnostics) 3-Year Book Growth Rate : 5.60% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics stock hits 52-week low at $1 amid market challenges - Investing.com Australia
CODX (Co-Diagnostics) Momentum Rank : 8 (As of Nov. 26, 2024) - GuruFocus.com
Co-Diagnostics, Inc. to Host Booth at the 2024 UHCA/UCAL Fall Convention & Expo on Oct 2-3 - GuruFocus.com
Co-Diagnostics stock hits 52-week low at $1 amid market challenges By Investing.com - Investing.com South Africa
CODX (Co-Diagnostics) 3-Year EPS without NRI Growth Rate : 0.00% (As of Sep. 2024) - GuruFocus.com
Co-Diagnostics (HAM:C97) Cash Flow from Discontinued Operat - GuruFocus.com
Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results - GuruFocus.com
Co-Diagnostics (LTS:0A50) Total Liabilities : $8.60 Mil (As of Sep. 2024) - GuruFocus.com
Daxor (NASDAQ:DXR) & Co-Diagnostics (NASDAQ:CODX) Critical Survey - Defense World
Co-Diagnostics, Inc. (CODX) Reports Q3 Loss, Tops Revenue Estimates - MSN
Leading Molecular Diagnostics Company BillionToOne Announces Three Executive Appointments Amid Rapid Growth - PR Newswire
Co-Diagnostics Q3 2024 Earnings Preview - MSN
Co-Diagnostics Third Quarter 2024 Earnings: Beats Expectations - Simply Wall St
Co-Diagnostics, Inc. (NASDAQ:CODX) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: Co-Diagnostics reports decreased Q3 revenue, eyes growth By Investing.com - Investing.com Australia
Co Diagnostics Inc (CODX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.33%
0.49%
자본화:
|
볼륨(24시간):